99% Savings - Buy Just @1 Rs X
StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop safe for pregnant women?
StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop again without your doctor's advice.
Is the use of StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop safe during breastfeeding?
Taking StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop may lead to serious side effects if you are breastfeeding. StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop on the Kidneys?
StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop is not harmful for kidneys.
What is the effect of StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop on the Liver?
There are no any side effects of StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop on the liver.
What is the effect of StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop on the Heart?
StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop is completely safe for the heart.
StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop unless your doctor advises you to do so -
Is this StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop habit forming or addictive?
Forming a habit of StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop has not been reported.
Interaction between Food and StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop
Eating certain foods may increase the time it takes StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop to have an effect. You should consult your doctor about it.
Interaction between Alcohol and StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop
Due to lack of research, there is no information about the side effects of taking StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop with alcohol.
Yes, StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop is an anti-inflammatory drug. It used for the treatment of a number of inflammatory and autoimmune conditions.
No, You should not discontinue StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop on your own. It may cause some serious side effects if you suddenly stop taking this medication. You are recommended to consult your doctor before discontinuing this medicine on your own.
Take [medicine] with food or milk to prevent stomach upset, exactly as prescribed by the doctor. Do not exceed more than the prescribed duration of the medicine course.
Yes, StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop is safe to use, if taken prescribed amount for a specified time as advised by the doctor. However, very few side effects are observed such as dizziness, insomnia, headache, weight gain, stomach pain, bloating, and sweating.
Yes, StayHappi Gatifloxacin + Prednisolone Acetate Eye Drop has immunosuppressant properties ( suppress the body's immune system). Hence, it used to treat a number of auto-immune conditions.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Orapred ODT® (prednisolone sodium phosphate
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; ZymaxidY™ (gatifloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1399